| (+)-pilocarpine | decreases expression | EXP | | 6480464 | Pilocarpine results in decreased expression of CDKN2A mRNA | CTD | PMID:17971868 |
| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of CDKN2A mRNA | CTD | PMID:17971868 |
| (-)-epigallocatechin 3-gallate | decreases metabolic processing | ISO | RGD:737039 | 6480464 | epigallocatechin gallate results in decreased metabolism of CDKN2A promoter | CTD | PMID:16037419 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:737039 | 6480464 | epigallocatechin gallate results in increased expression of CDKN2A protein | CTD | PMID:17683969 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:737039 | 6480464 | epigallocatechin gallate results in increased expression of CDKN2A mRNA | CTD | PMID:14633667 |
| (-)-epigallocatechin 3-gallate | decreases methylation | ISO | RGD:737039 | 6480464 | epigallocatechin gallate results in decreased methylation of CDKN2A promoter | CTD | PMID:14633667 |
| (-)-epigallocatechin 3-gallate | decreases methylation | ISO | RGD:737039 | 6480464 | epigallocatechin gallate results in decreased methylation of CDKN2A gene | CTD | PMID:17683969 |
| 17beta-estradiol | decreases expression | ISO | RGD:737039 | 6480464 | Estradiol results in decreased expression of CDKN2A mRNA | CTD | PMID:19027819 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | RGD:737039 | 6480464 | Metribolone results in increased expression of CDKN2A protein | CTD | PMID:23272087 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737039 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDKN2A protein | CTD | PMID:17070097 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CDKN2A mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737039 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDKN2A mRNA | CTD | PMID:17257637 PMID:17070097 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10322 | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of CDKN2A mRNA; more ... | CTD | PMID:21167638 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737039 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CDKN2A mRNA | CTD | PMID:17070097 PMID:17257637 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CDKN2A mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of CDKN2A mRNA | CTD | PMID:19167416 |
| 2-acetamidofluorene | increases methylation | EXP | | 6480464 | 2-Acetylaminofluorene results in increased methylation of CDKN2A promoter | CTD | PMID:20188851 |
| 2-acetamidofluorene | increases methylation | EXP | | 6480464 | 2-Acetylaminofluorene results in increased methylation of CDKN2A gene | CTD | PMID:18204080 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A mRNA; more ... | CTD | PMID:16317707 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | RGD:10322 | 6480464 | [Tetrachlorodibenzodioxin co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in decreased expression of CDKN2A mRNA; more ... | CTD | PMID:21167638 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:737039 | 6480464 | Fenretinide results in increased expression of CDKN2A protein | CTD | PMID:16570282 |
| 4-phenylbutyric acid | multiple interactions | ISO | RGD:737039 | 6480464 | [4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN2A mRNA | CTD | PMID:17210717 |
| 4-vinylcyclohexene dioxide | increases expression | ISO | RGD:10322 | 6480464 | 4-vinyl-1-cyclohexene dioxide results in increased expression of CDKN2A mRNA | CTD | PMID:20829426 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN2A mRNA | CTD | PMID:17210717 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A protein | CTD | PMID:12859993 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | arsenic trioxide promotes the reaction [decitabine results in increased expression of CDKN2A mRNA]; more ... | CTD | PMID:16613325 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A protein | CTD | PMID:12859993 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:16367923 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine results in decreased methylation of CDKN2A promoter] which results in increased expression of CDKN2A mRNA | CTD | PMID:16613325 more ... |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A promoter | CTD | PMID:16613325 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | decitabine inhibits the reaction [arsenite results in decreased expression of CDKN2A protein] | CTD | PMID:21040761 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:16367923 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A protein | CTD | PMID:19372550 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:21515334 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:737039 | 6480464 | decitabine results in decreased expression of CDKN2A mRNA | CTD | PMID:19027819 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA | CTD | PMID:18454857 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:19372550 more ... |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A promoter | CTD | PMID:19372550 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | decitabine inhibits the reaction [Cadmium Chloride results in increased methylation of CDKN2A promoter]; more ... | CTD | PMID:17938735 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA | CTD | PMID:18454857 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A protein | CTD | PMID:17389721 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A protein | CTD | PMID:17389721 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:19732952 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine results in decreased methylation of CDKN2A promoter] which results in increased expression of CDKN2A mRNA | CTD | PMID:17195906 PMID:17195906 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A promoter | CTD | PMID:17195906 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [[decitabine co-treated with trichostatin A] affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA; more ... | CTD | PMID:18813790 PMID:18813790 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA | CTD | PMID:18454857 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of CDKN2A gene] which affects the expression of CDKN2A mRNA | CTD | PMID:18410530 PMID:18410530 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:19372550 more ... |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A promoter | CTD | PMID:19372550 more ... |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A gene | CTD | PMID:12859993 PMID:17686055 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA | CTD | PMID:18454857 PMID:18813790 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:737039 | 6480464 | decitabine affects the methylation of CDKN2A promoter | CTD | PMID:18069755 PMID:17571247 |
| 5-aza-2'-deoxycytidine | increases phosphorylation | ISO | RGD:737039 | 6480464 | decitabine results in increased phosphorylation of CDKN2A protein | CTD | PMID:19732952 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A protein | CTD | PMID:12859993 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:19417133 more ... |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A protein | CTD | PMID:19732952 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | Hydroxyurea inhibits the reaction [decitabine results in decreased methylation of CDKN2A gene] | CTD | PMID:17686055 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | HSPA9 protein promotes the reaction [decitabine results in increased expression of CDKN2A protein]; more ... | CTD | PMID:17389721 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A protein | CTD | PMID:12859993 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA alternative form | CTD | PMID:17195906 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:737039 | 6480464 | decitabine results in increased expression of CDKN2A mRNA | CTD | PMID:18845559 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine results in decreased methylation of CDKN2A promoter] which results in increased expression of CDKN2A mRNA | CTD | PMID:17195906 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A promoter | CTD | PMID:19417133 more ... |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:737039 | 6480464 | decitabine results in decreased methylation of CDKN2A gene | CTD | PMID:17686055 PMID:12859993 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine co-treated with trichostatin A] affects the methylation of CDKN2A promoter | CTD | PMID:18069755 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine co-treated with trichostatin A] affects the expression of CDKN2A protein | CTD | PMID:17019711 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [[decitabine co-treated with scriptaid] affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA; more ... | CTD | PMID:18813790 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of HIST3H3 protein] which affects the methylation of CDKN2A gene | CTD | PMID:18410530 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA | CTD | PMID:18813790 PMID:18454857 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine affects the methylation of CDKN2A gene] which affects the expression of CDKN2A mRNA | CTD | PMID:18410530 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:737039 | 6480464 | decitabine affects the methylation of CDKN2A promoter | CTD | PMID:17571247 PMID:18069755 |
| 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:737039 | 6480464 | decitabine affects the expression of CDKN2A mRNA | CTD | PMID:17194187 |
| 5-azacytidine | affects methylation | ISO | RGD:737039 | 6480464 | Azacitidine affects the methylation of CDKN2A gene | CTD | PMID:18443271 |
| 5-azacytidine | increases expression | EXP | | 6480464 | Azacitidine results in increased expression of CDKN2A mRNA | CTD | PMID:21224363 |
| 5-azacytidine | decreases methylation | EXP | | 6480464 | Azacitidine results in decreased methylation of CDKN2A gene | CTD | PMID:21224363 |
| 5-azacytidine | multiple interactions | EXP | | 6480464 | [Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in decreased methylation of CDKN2A gene; more ... | CTD | PMID:21224363 |
| 5-azacytidine | multiple interactions | ISO | RGD:737039 | 6480464 | Hydroxyurea inhibits the reaction [Azacitidine results in decreased methylation of CDKN2A gene] | CTD | PMID:17686055 |
| 5-azacytidine | increases expression | ISO | RGD:737039 | 6480464 | Azacitidine results in increased expression of CDKN2A mRNA | CTD | PMID:15547111 |
| 5-azacytidine | decreases methylation | ISO | RGD:737039 | 6480464 | Azacitidine results in decreased methylation of CDKN2A gene | CTD | PMID:17686055 |
| 5-azacytidine | decreases metabolic processing | ISO | RGD:737039 | 6480464 | Azacitidine results in decreased metabolism of CDKN2A promoter | CTD | PMID:15547111 |
| 5-fluorouracil | decreases expression | ISO | RGD:737039 | 6480464 | Fluorouracil results in decreased expression of CDKN2A protein | CTD | PMID:17982676 |
| 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CDKN2A mRNA | CTD | PMID:22504374 |
| 7,12-dimethyltetraphene | increases response to substance | ISO | RGD:10322 | 6480464 | CDKN2A gene polymorphism results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene | CTD | PMID:11544531 |
| all-trans-retinoic acid | increases expression | ISO | RGD:737039 | 6480464 | Tretinoin results in increased expression of CDKN2A mRNA | CTD | PMID:17138961 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:737039 | 6480464 | Tretinoin results in decreased expression of CDKN2A mRNA | CTD | PMID:16494909 |
| ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of CDKN2A protein | CTD | PMID:16483693 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CDKN2A mRNA | CTD | PMID:16483693 |
| arsenic atom | increases methylation | ISO | RGD:737039 | 6480464 | Arsenic results in increased methylation of CDKN2A promoter | CTD | PMID:16251483 |
| arsenic atom | increases expression | ISO | RGD:737039 | 6480464 | Arsenic results in increased expression of CDKN2A mRNA | CTD | PMID:12773770 |
| arsenite(3-) | decreases expression | ISO | RGD:737039 | 6480464 | arsenite results in decreased expression of CDKN2A protein; more ... | CTD | PMID:21040761 |
| arsenite(3-) | multiple interactions | ISO | RGD:737039 | 6480464 | decitabine inhibits the reaction [arsenite results in decreased expression of CDKN2A protein]; more ... | CTD | PMID:21040761 |
| arsenite(3-) | increases methylation | ISO | RGD:737039 | 6480464 | arsenite results in increased methylation of CDKN2A gene | CTD | PMID:21040761 |
| asbestos | increases methylation | ISO | RGD:737039 | 6480464 | Asbestos results in increased methylation of CDKN2A promoter | CTD | PMID:15911247 |
| asbestos | decreases expression | ISO | RGD:737039 | 6480464 | Asbestos results in decreased expression of CDKN2A mRNA | CTD | PMID:22076105 |
| benzene | multiple interactions | ISO | RGD:737039 | 6480464 | [Benzene results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA | CTD | PMID:20044985 PMID:20044985 |
| benzene | affects response to substance | ISO | RGD:737039 | 6480464 | CDKN2A gene polymorphism affects the susceptibility to Benzene | CTD | PMID:19596022 |
| benzene | multiple interactions | ISO | RGD:737039 | 6480464 | MDM2 gene polymorphism affects the reaction [CDKN2A gene polymorphism affects the susceptibility to Benzene] | CTD | PMID:19596022 |
| benzene | multiple interactions | ISO | RGD:737039 | 6480464 | [Benzene results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA | CTD | PMID:20044985 |
| benzene | decreases expression | ISO | RGD:737039 | 6480464 | Benzene results in decreased expression of CDKN2A mRNA | CTD | PMID:20044985 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CDKN2A mRNA | CTD | PMID:19408242 PMID:20064080 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10322 | 6480464 | Benzo(a)pyrene affects the reaction [sodium bichromate results in decreased expression of CDKN2A mRNA] | CTD | PMID:22613061 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CDKN2A protein | CTD | PMID:20064080 PMID:21467743 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CDKN2A mRNA | CTD | PMID:20064080 PMID:19408242 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in decreased expression of CDKN2A protein]; more ... | CTD | PMID:20064080 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of CDKN2A mRNA; more ... | CTD | PMID:19408242 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CDKN2A protein | CTD | PMID:19408242 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CDKN2A protein | CTD | PMID:20064080 |
| beryllium atom | multiple interactions | EXP | | 6480464 | [Beryllium results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA | CTD | PMID:11872642 |
| beryllium atom | multiple interactions | EXP | | 6480464 | [Beryllium results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA | CTD | PMID:11872642 PMID:11872642 |
| beryllium sulfate | increases expression | ISO | RGD:737039 | 6480464 | beryllium sulfate results in increased expression of CDKN2A mRNA; more ... | CTD | PMID:17395767 |
| beryllium(0) | multiple interactions | EXP | | 6480464 | [Beryllium results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA | CTD | PMID:11872642 |
| beryllium(0) | multiple interactions | EXP | | 6480464 | [Beryllium results in increased methylation of CDKN2A promoter] which results in decreased expression of CDKN2A mRNA | CTD | PMID:11872642 PMID:11872642 |
| bisphenol A | increases expression | ISO | RGD:737039 | 6480464 | bisphenol A results in increased expression of CDKN2A protein | CTD | PMID:22258036 |
| bisphenol A | increases methylation | ISO | RGD:737039 | 6480464 | bisphenol A results in increased methylation of CDKN2A gene | CTD | PMID:22258036 |
| busulfan | increases expression | ISO | RGD:10322 | 6480464 | Busulfan results in increased expression of CDKN2A mRNA | CTD | PMID:14500376 |
| C60 fullerene | increases expression | ISO | RGD:737039 | 6480464 | fullerene C60 analog results in increased expression of CDKN2A protein | CTD | PMID:20045429 |
| cadmium atom | increases methylation | ISO | RGD:737039 | 6480464 | Cadmium results in increased methylation of CDKN2A promoter | CTD | PMID:17938735 |
| cadmium dichloride | multiple interactions | ISO | RGD:737039 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of CDKN2A mRNA | CTD | PMID:12634122 |
| cadmium dichloride | multiple interactions | ISO | RGD:737039 | 6480464 | decitabine inhibits the reaction [Cadmium Chloride results in decreased expression of CDKN2A protein]; more ... | CTD | PMID:17938735 |
| cadmium dichloride | decreases expression | ISO | RGD:737039 | 6480464 | Cadmium Chloride results in decreased expression of CDKN2A protein | CTD | PMID:17938735 |
| calcium dichloride | multiple interactions | EXP | | 6480464 | Calcium Chloride inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA]; more ... | CTD | PMID:12189186 |
| capecitabine | decreases expression | ISO | RGD:737039 | 6480464 | capecitabine results in decreased expression of CDKN2A protein | CTD | PMID:17904787 |
| capsaicin | increases expression | ISO | RGD:737039 | 6480464 | Capsaicin results in increased expression of CDKN2A mRNA | CTD | PMID:18533110 |
| carmustine | increases response to substance | ISO | RGD:737039 | 6480464 | CDKN2A protein results in increased susceptibility to Carmustine | CTD | PMID:16786135 |
| chloramphenicol | increases expression | ISO | RGD:737039 | 6480464 | Chloramphenicol results in increased expression of CDKN2A protein | CTD | PMID:15905168 |
| chromium atom | affects methylation | ISO | RGD:737039 | 6480464 | Chromium affects the methylation of CDKN2A protein | CTD | PMID:16828922 |
| chromium atom | decreases expression | ISO | RGD:737039 | 6480464 | Chromium results in decreased expression of CDKN2A protein | CTD | PMID:16828922 |
| chromium(6+) | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in increased expression of CDKN2A protein] | CTD | PMID:21621607 |
| chromium(6+) | increases expression | EXP | | 6480464 | chromium hexavalent ion results in increased expression of CDKN2A protein | CTD | PMID:21621607 |
| cisplatin | decreases expression | ISO | RGD:737039 | 6480464 | Cisplatin results in decreased expression of CDKN2A protein | CTD | PMID:16797627 |
| cisplatin | increases expression | ISO | RGD:737039 | 6480464 | Cisplatin results in increased expression of CDKN2A protein | CTD | PMID:16797627 PMID:20540955 |
| cisplatin | increases expression | ISO | RGD:737039 | 6480464 | Cisplatin results in increased expression of CDKN2A protein; more ... | CTD | PMID:16797627 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN2A mRNA | CTD | PMID:17602206 |
| copper atom | decreases expression | ISO | RGD:737039 | 6480464 | Copper results in decreased expression of CDKN2A protein | CTD | PMID:16246896 |
| copper atom | multiple interactions | ISO | RGD:737039 | 6480464 | [Copper results in increased activity of TP53 protein] which results in increased expression of CDKN2A mRNA | CTD | PMID:16391388 |
| copper(0) | decreases expression | ISO | RGD:737039 | 6480464 | Copper results in decreased expression of CDKN2A protein | CTD | PMID:16246896 |
| copper(0) | multiple interactions | ISO | RGD:737039 | 6480464 | [Copper results in increased activity of TP53 protein] which results in increased expression of CDKN2A mRNA | CTD | PMID:16391388 |
| copper(2+) sulfate | increases expression | ISO | RGD:737039 | 6480464 | Copper Sulfate results in increased expression of CDKN2A mRNA | CTD | PMID:19549813 |
| corticosterone | decreases expression | EXP | | 6480464 | Corticosterone results in decreased expression of CDKN2A mRNA | CTD | PMID:15755911 |
| curcumin | decreases expression | ISO | RGD:737039 | 6480464 | Curcumin results in decreased expression of CDKN2A protein | CTD | PMID:17148446 |
| curcumin | increases expression | ISO | RGD:737039 | 6480464 | Curcumin results in increased expression of CDKN2A protein | CTD | PMID:18156803 |
| cycloheximide | increases expression | ISO | RGD:737039 | 6480464 | Cycloheximide results in increased expression of CDKN2A mRNA | CTD | PMID:17257637 |
| daunorubicin | affects expression | ISO | RGD:737039 | 6480464 | Daunorubicin affects the expression of CDKN2A mRNA | CTD | PMID:12656675 |
| dehydroepiandrosterone | increases expression | EXP | | 6480464 | Dehydroepiandrosterone results in increased expression of CDKN2A protein | CTD | PMID:16457693 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:10322 | 6480464 | Tetrahydrocannabinol results in increased expression of CDKN2A mRNA | CTD | PMID:21542829 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:737039 | 6480464 | Tetrahydrocannabinol results in increased expression of CDKN2A protein | CTD | PMID:17934890 |
| diarsenic trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | [arsenic trioxide results in decreased methylation of CDKN2A gene] which results in increased expression of CDKN2A mRNA | CTD | PMID:20416177 PMID:20416177 |
| diarsenic trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | arsenic trioxide promotes the reaction [decitabine results in increased expression of CDKN2A mRNA]; more ... | CTD | PMID:16613325 |
| diarsenic trioxide | increases expression | ISO | RGD:737039 | 6480464 | arsenic trioxide results in increased expression of CDKN2A mRNA | CTD | PMID:15191659 more ... |
| diarsenic trioxide | decreases methylation | ISO | RGD:737039 | 6480464 | arsenic trioxide results in decreased methylation of CDKN2A promoter | CTD | PMID:16008847 PMID:16613325 |
| diarsenic trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | [arsenic trioxide results in decreased methylation of CDKN2A promoter] which results in increased expression of CDKN2A mRNA | CTD | PMID:16613325 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:737039 | 6480464 | arsenic trioxide results in increased expression of CDKN2A mRNA | CTD | PMID:19769630 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:737039 | 6480464 | arsenic trioxide results in increased expression of CDKN2A mRNA | CTD | PMID:19769630 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:737039 | 6480464 | arsenic trioxide results in increased expression of CDKN2A mRNA | CTD | PMID:16008847 more ... |
| diarsenic trioxide | increases expression | ISO | RGD:737039 | 6480464 | arsenic trioxide results in increased expression of CDKN2A protein | CTD | PMID:15191659 |
| diarsenic trioxide | increases expression | ISO | RGD:737039 | 6480464 | arsenic trioxide results in increased expression of CDKN2A gene | CTD | PMID:21544632 |
| diarsenic trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | [arsenic trioxide results in decreased methylation of CDKN2A promoter] which results in increased expression of CDKN2A mRNA | CTD | PMID:20596618 |
| diarsenic trioxide | decreases methylation | ISO | RGD:737039 | 6480464 | arsenic trioxide results in decreased methylation of CDKN2A promoter | CTD | PMID:16008847 |
| diarsenic trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | [arsenic trioxide results in decreased methylation of CDKN2A gene] which results in increased expression of CDKN2A mRNA | CTD | PMID:20416177 |
| diarsenic trioxide | decreases methylation | ISO | RGD:737039 | 6480464 | arsenic trioxide results in decreased methylation of CDKN2A gene | CTD | PMID:15191659 |
| diarsenic trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CDKN2A mRNA | CTD | PMID:18922899 |
| diarsenic trioxide | increases expression | ISO | RGD:737039 | 6480464 | arsenic trioxide results in increased expression of CDKN2A mRNA | CTD | PMID:15191659 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | [arsenic trioxide results in decreased methylation of CDKN2A promoter] which results in increased expression of CDKN2A mRNA | CTD | PMID:20596618 PMID:20596618 |
| dichromium trioxide | multiple interactions | ISO | RGD:737039 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of CDKN2A mRNA | CTD | PMID:12634122 |
| dimethylarsinic acid | decreases expression | EXP | | 6480464 | Cacodylic Acid results in decreased expression of CDKN2A mRNA | CTD | PMID:16122865 |
| docetaxel anhydrous | decreases expression | ISO | RGD:737039 | 6480464 | docetaxel results in decreased expression of CDKN2A protein | CTD | PMID:16797627 |
| doxorubicin | increases expression | ISO | RGD:737039 | 6480464 | Doxorubicin results in increased expression of CDKN2A mRNA | CTD | PMID:16705698 |
| fluoxetine | increases expression | ISO | RGD:10322 | 6480464 | Fluoxetine results in increased expression of CDKN2A mRNA | CTD | PMID:21497159 |
| folic acid | affects methylation | ISO | RGD:737039 | 6480464 | Folic Acid affects the methylation of CDKN2A promoter | CTD | PMID:16646054 |
| folic acid | affects expression | ISO | RGD:10322 | 6480464 | Folic Acid affects the expression of CDKN2A mRNA | CTD | PMID:17585020 |
| folic acid | affects methylation | ISO | RGD:10322 | 6480464 | Folic Acid affects the methylation of CDKN2A promoter | CTD | PMID:17585020 |
| folic acid | multiple interactions | ISO | RGD:737039 | 6480464 | MTHFR gene polymorphism affects the reaction [Folic Acid affects the methylation of CDKN2A promoter] | CTD | PMID:16646054 |
| fumonisin B1 | increases expression | ISO | RGD:10322 | 6480464 | fumonisin B1 results in increased expression of CDKN2A mRNA | CTD | PMID:16221962 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of CDKN2A mRNA | CTD | PMID:20562052 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of CDKN2A mRNA | CTD | PMID:20562052 PMID:22079235 |
| glycine betaine | multiple interactions | EXP | | 6480464 | Betaine promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN2A mRNA] | CTD | PMID:19642983 |
| hydralazine | decreases methylation | ISO | RGD:737039 | 6480464 | Hydralazine results in decreased methylation of CDKN2A promoter | CTD | PMID:15862127 |
| hydralazine | multiple interactions | EXP | | 6480464 | [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [desoxycortone acetate results in increased expression of CDKN2A mRNA]; more ... | CTD | PMID:18504326 |
| hydrogen peroxide | affects expression | ISO | RGD:737039 | 6480464 | Hydrogen Peroxide affects the expression of CDKN2A protein | CTD | PMID:21179406 |
| hydroxyurea | multiple interactions | ISO | RGD:737039 | 6480464 | Hydroxyurea inhibits the reaction [Azacitidine results in decreased methylation of CDKN2A gene]; more ... | CTD | PMID:17686055 |
| hydroxyurea | increases expression | ISO | RGD:737039 | 6480464 | Hydroxyurea results in increased expression of CDKN2A protein | CTD | PMID:10961388 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in increased expression of CDKN2A protein] | CTD | PMID:21621607 |
| lead diacetate | multiple interactions | ISO | RGD:737039 | 6480464 | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of CDKN2A mRNA | CTD | PMID:12634122 |
| lidocaine | affects expression | ISO | RGD:10322 | 6480464 | Lidocaine affects the expression of CDKN2A mRNA | CTD | PMID:18931217 |
| LY294002 | multiple interactions | ISO | RGD:737039 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDKN2A mRNA] | CTD | PMID:12710931 |
| menadione | increases expression | ISO | RGD:737039 | 6480464 | Vitamin K 3 results in increased expression of CDKN2A mRNA | CTD | PMID:16010434 |
| menaquinone | increases expression | ISO | RGD:737039 | 6480464 | Vitamin K 2 results in increased expression of CDKN2A mRNA | CTD | PMID:16010434 |
| methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of CDKN2A mRNA | CTD | PMID:22504374 |
| methoxychlor | increases expression | ISO | RGD:10322 | 6480464 | Methoxychlor results in increased expression of CDKN2A mRNA | CTD | PMID:20829426 |
| methylmercury chloride | decreases expression | ISO | RGD:10322 | 6480464 | methylmercuric chloride results in decreased expression of CDKN2A mRNA | CTD | PMID:20061341 |
| methylmercury chloride | decreases methylation | EXP | | 6480464 | methylmercuric chloride results in decreased methylation of CDKN2A promoter | CTD | PMID:19636072 |
| myo-inositol hexakisphosphate | multiple interactions | ISO | RGD:10322 | 6480464 | Phytic Acid inhibits the reaction [Ethylnitrosourea results in decreased expression of CDKN2A] | CTD | PMID:21154115 |
| myo-inositol hexakisphosphate | affects methylation | ISO | RGD:10322 | 6480464 | Phytic Acid affects the methylation of CDKN2A promoter | CTD | PMID:21154115 |
| N-ethyl-N-nitrosourea | increases response to substance | ISO | RGD:10322 | 6480464 | CDKN2A gene mutant form results in increased susceptibility to Ethylnitrosourea | CTD | PMID:17943659 |
| N-ethyl-N-nitrosourea | multiple interactions | ISO | RGD:10322 | 6480464 | Phytic Acid inhibits the reaction [Ethylnitrosourea results in decreased expression of CDKN2A] | CTD | PMID:21154115 |
| N-ethyl-N-nitrosourea | decreases expression | ISO | RGD:10322 | 6480464 | Ethylnitrosourea results in decreased expression of CDKN2A | CTD | PMID:21154115 |
| N-methyl-4-phenylpyridinium | multiple interactions | ISO | RGD:737039 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDKN2A mRNA] | CTD | PMID:12710931 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10322 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDKN2A protein | CTD | PMID:15082532 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10322 | 6480464 | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of CDKN2A mRNA | CTD | PMID:23288052 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CDKN2A mRNA | CTD | PMID:19642983 PMID:20360939 |
| N-nitrosodiethylamine | increases methylation | EXP | | 6480464 | Diethylnitrosamine results in increased methylation of CDKN2A promoter | CTD | PMID:19642983 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CDKN2A mRNA | CTD | PMID:20360939 PMID:19642983 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN2A mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN2A mRNA] | CTD | PMID:20360939 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | Betaine promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN2A mRNA] | CTD | PMID:19642983 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10322 | 6480464 | Diethylnitrosamine results in increased expression of CDKN2A protein | CTD | PMID:19919837 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10322 | 6480464 | ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDKN2A protein] | CTD | PMID:19919837 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of CDKN2A protein; more ... | CTD | PMID:16317707 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of CDKN2A mRNA | CTD | PMID:15138612 |
| nordihydroguaiaretic acid | increases expression | ISO | RGD:737039 | 6480464 | Nordihydroguaiaretic Acid results in increased expression of CDKN2A protein; more ... | CTD | PMID:18164318 |
| nordihydroguaiaretic acid | decreases methylation | ISO | RGD:737039 | 6480464 | Nordihydroguaiaretic Acid results in decreased methylation of CDKN2A promoter | CTD | PMID:18164318 |
| parathion | increases expression | ISO | RGD:737039 | 6480464 | Parathion results in increased expression of CDKN2A mRNA | CTD | PMID:17390078 |
| perfluorooctanoic acid | increases expression | ISO | RGD:737039 | 6480464 | perfluorooctanoic acid results in increased expression of CDKN2A mRNA | CTD | PMID:22425687 |
| phenobarbital | multiple interactions | ISO | RGD:10322 | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDKN2A protein | CTD | PMID:15082532 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:737039 | 6480464 | [arsenic trioxide co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CDKN2A mRNA | CTD | PMID:18922899 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:10322 | 6480464 | [sodium arsenite co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CDKN2A mRNA | CTD | PMID:16368122 |
| pirinixic acid | multiple interactions | ISO | RGD:737039 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CDKN2A mRNA | CTD | PMID:19710929 |
| pirinixic acid | multiple interactions | ISO | RGD:10322 | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased expression of CDKN2A mRNA] | CTD | PMID:16221962 |
| pirinixic acid | increases expression | ISO | RGD:10322 | 6480464 | pirinixic acid results in increased expression of CDKN2A mRNA | CTD | PMID:16221962 |
| piroxicam | multiple interactions | EXP | | 6480464 | Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA]; more ... | CTD | PMID:12189186 |
| prednisone | increases expression | ISO | RGD:737039 | 6480464 | Prednisone results in increased expression of CDKN2A protein | CTD | PMID:15034294 |
| procainamide | increases expression | ISO | RGD:737039 | 6480464 | Procainamide results in increased expression of CDKN2A protein | CTD | PMID:17938735 |
| quercetin | decreases methylation | ISO | RGD:737039 | 6480464 | Quercetin results in decreased methylation of CDKN2A promoter | CTD | PMID:18974642 |
| quinoline | increases expression | ISO | RGD:737039 | 6480464 | quinoline analog results in increased expression of CDKN2A mRNA; more ... | CTD | PMID:19417133 |
| quinoline | decreases methylation | ISO | RGD:737039 | 6480464 | quinoline analog results in decreased methylation of CDKN2A promoter | CTD | PMID:19417133 |
| radon atom | increases methylation | ISO | RGD:737039 | 6480464 | Radon results in increased methylation of CDKN2A promoter | CTD | PMID:16902270 |
| radon(0) | increases methylation | ISO | RGD:737039 | 6480464 | Radon results in increased methylation of CDKN2A promoter | CTD | PMID:16902270 |
| reserpine | multiple interactions | EXP | | 6480464 | [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine] inhibits the reaction [desoxycortone acetate affects the localization of CDKN2A protein]; more ... | CTD | PMID:18504326 |
| resveratrol | decreases expression | ISO | RGD:737039 | 6480464 | resveratrol results in decreased expression of CDKN2A mRNA | CTD | PMID:17804521 |
| S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | RGD:10322 | 6480464 | S-(1,2-dichlorovinyl)cysteine results in decreased expression of CDKN2A protein | CTD | PMID:16495211 |
| silver(1+) nitrate | increases expression | ISO | RGD:737039 | 6480464 | Silver Nitrate results in increased expression of CDKN2A mRNA | CTD | PMID:22831968 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of CDKN2A protein | CTD | PMID:18804536 |
| sodium dichromate | decreases expression | ISO | RGD:10322 | 6480464 | sodium bichromate results in decreased expression of CDKN2A mRNA | CTD | PMID:22613061 |
| sodium dichromate | multiple interactions | ISO | RGD:10322 | 6480464 | Benzo(a)pyrene affects the reaction [sodium bichromate results in decreased expression of CDKN2A mRNA] | CTD | PMID:22613061 |
| spironolactone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [desoxycortone acetate affects the localization of CDKN2A protein]; more ... | CTD | PMID:18504326 |
| stavudine | affects expression | ISO | RGD:10322 | 6480464 | Stavudine affects the expression of CDKN2A protein | CTD | PMID:18389896 |
| sulfur dioxide | multiple interactions | EXP | | 6480464 | [Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of CDKN2A mRNA; more ... | CTD | PMID:19408242 |
| sulfur dioxide | decreases expression | EXP | | 6480464 | Sulfur Dioxide results in decreased expression of CDKN2A mRNA | CTD | PMID:19408242 more ... |
| sulfur dioxide | decreases expression | EXP | | 6480464 | Sulfur Dioxide results in decreased expression of CDKN2A protein | CTD | PMID:19434695 PMID:20064080 |
| sulfur dioxide | decreases expression | EXP | | 6480464 | Sulfur Dioxide results in decreased expression of CDKN2A mRNA | CTD | PMID:19408242 PMID:20064080 |
| sulfur dioxide | increases expression | EXP | | 6480464 | Sulfur Dioxide results in increased expression of CDKN2A protein | CTD | PMID:19408242 |
| sulfur dioxide | decreases expression | EXP | | 6480464 | Sulfur Dioxide results in decreased expression of CDKN2A protein | CTD | PMID:20064080 |
| sulfur dioxide | multiple interactions | EXP | | 6480464 | Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in decreased expression of CDKN2A mRNA]; more ... | CTD | PMID:20064080 |
| sulfur dioxide | decreases expression | EXP | | 6480464 | Sulfur Dioxide results in decreased expression of CDKN2A mRNA | CTD | PMID:20064080 PMID:19408242 |
| sulindac | multiple interactions | EXP | | 6480464 | Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA] | CTD | PMID:12189186 |
| terephthalic acid | decreases expression | EXP | | 6480464 | terephthalic acid results in decreased expression of CDKN2A protein | CTD | PMID:16896691 |
| tetrachloromethane | multiple interactions | ISO | RGD:10322 | 6480464 | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of CDKN2A mRNA | CTD | PMID:23288052 |
| tetrachloromethane | increases expression | ISO | RGD:10322 | 6480464 | Carbon Tetrachloride results in increased expression of CDKN2A mRNA | CTD | PMID:23288052 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CDKN2A protein | CTD | PMID:22659510 |
| thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CDKN2A mRNA | CTD | PMID:22659510 |
| thioacetamide | affects localization | EXP | | 6480464 | Thioacetamide affects the localization of CDKN2A protein | CTD | PMID:22659510 |
| thioridazine | increases expression | ISO | RGD:737039 | 6480464 | Thioridazine results in increased expression of CDKN2A protein | CTD | PMID:21035837 |
| trans-resveratrol | decreases expression | ISO | RGD:737039 | 6480464 | resveratrol results in decreased expression of CDKN2A mRNA | CTD | PMID:17804521 |
| trichostatin A | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine co-treated with trichostatin A] affects the expression of CDKN2A protein | CTD | PMID:17019711 |
| trichostatin A | multiple interactions | ISO | RGD:737039 | 6480464 | [[decitabine co-treated with trichostatin A] affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA | CTD | PMID:18813790 PMID:18813790 |
| trichostatin A | decreases expression | ISO | RGD:737039 | 6480464 | trichostatin A results in decreased expression of CDKN2A mRNA | CTD | PMID:19606018 |
| trichostatin A | multiple interactions | ISO | RGD:737039 | 6480464 | [[decitabine co-treated with trichostatin A] affects the methylation of CDKN2A promoter] which affects the expression of CDKN2A mRNA | CTD | PMID:18813790 |
| trichostatin A | multiple interactions | ISO | RGD:737039 | 6480464 | [decitabine co-treated with trichostatin A] affects the methylation of CDKN2A promoter | CTD | PMID:18069755 |
| urethane | decreases expression | ISO | RGD:10322 | 6480464 | Urethane results in decreased expression of CDKN2A mRNA | CTD | PMID:12117781 |
| urethane | increases response to substance | ISO | RGD:10322 | 6480464 | CDKN2A gene polymorphism results in increased susceptibility to Urethane | CTD | PMID:11544531 |
| valproic acid | increases expression | ISO | RGD:737039 | 6480464 | Valproic Acid results in increased expression of CDKN2A mRNA | CTD | PMID:19101580 |
| vincristine | increases response to substance | ISO | RGD:737039 | 6480464 | CDKN2A protein results in increased susceptibility to Vincristine | CTD | PMID:16786135 |
| vinorelbine | decreases expression | ISO | RGD:737039 | 6480464 | vinorelbine results in decreased expression of CDKN2A protein | CTD | PMID:17904787 |
| zidovudine | increases expression | ISO | RGD:737039 | 6480464 | Zidovudine results in increased expression of CDKN2A protein; more ... | CTD | PMID:16797627 |
| zidovudine | affects expression | ISO | RGD:10322 | 6480464 | Zidovudine affects the expression of CDKN2A protein | CTD | PMID:18389896 |
| zinc pyrithione | affects expression | ISO | RGD:737039 | 6480464 | zinc pyrithione affects the expression of CDKN2A protein | CTD | PMID:21557991 |